Business Context and Reporting Period
This Form 8-K Current Report was filed by Inpixon (trading symbol: INPX) on January 28, 2022. The filing discloses the entry into a Material Definitive Agreement and the unregistered sale of equity securities. Note: The request metadata references "XTI Aerospace, Inc.," but the filing text explicitly identifies the registrant as "Inpixon."
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on a capital structure transaction.
- Existing Warrants Cancelled: Warrants exercisable for 49,305,088 shares.
- Shares Issued Immediately: 13,811,407 shares of common stock.
- Reserved Shares (Rights): Rights to receive 3,938,424 shares.
- Total Exchange Shares: 17,749,831 shares (Issued + Reserved).
- Post-Transaction Outstanding Shares: 138,252,330 shares as of January 28, 2022.
Material Changes
The primary material change is the conversion of existing warrant obligations into common stock and rights. The Company entered into an Exchange Agreement to cancel warrants representing nearly 49.3 million shares in exchange for issuing approximately 13.8 million shares immediately and granting rights for an additional 3.9 million shares. This transaction was executed under Section 3(a)(9) of the Securities Act of 1933.
Guidance, Outlook, and Restrictions
The filing contains no financial guidance or management commentary regarding future operations. However, it outlines specific trading restrictions for the Warrant Holder:
- Restricted Period: From January 28, 2022, through March 29, 2022.
- Sale Limitation: During the Restricted Period, the Warrant Holder cannot sell more than 10% of the daily composite trading volume of the Company's common stock on any single trading day.
- Exercise Terms: The Rights for the Reserved Shares may be exercised at any time after the agreement date, subject to beneficial ownership limitations.
Investor Verification Checklist
- Verify the exact terms of the "Rights" to ensure understanding of the conditions under which the 3,938,424 Reserved Shares may be issued.
- Confirm the impact of the 138,252,330 outstanding share count on existing shareholder dilution.
- Review the attached Exhibit 10.1 (Exchange Agreement) for any omitted schedules or specific beneficial ownership limitations not detailed in the summary.
- Monitor trading volume during the Restricted Period (ending March 29, 2022) to assess potential liquidity constraints on the Warrant Holder's ability to exit the position.